Secondary prevention of congenital cytomegalovirus infection
- PMID: 32919497
- DOI: 10.1016/S0140-6736(20)31903-6
Secondary prevention of congenital cytomegalovirus infection
Comment on
-
Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.Lancet. 2020 Sep 12;396(10253):779-785. doi: 10.1016/S0140-6736(20)31868-7. Lancet. 2020. PMID: 32919517 Clinical Trial.
Dataset described in
-
Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.Lancet. 2020 Sep 12;396(10253):779-785. doi: 10.1016/S0140-6736(20)31868-7. Lancet. 2020. PMID: 32919517 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical